Follow CGSP on Social Media

Listen to the CGSP Podcast

Concerns Over Sinopharm’s Efficacy Prompts Some in UAE to Over-Vaccinate

Reports that the Chinese-made Sinopharm COVID-19 vaccine may be faltering against the onslaught of the Delta variant is prompting some in countries like the United Arab Emirates to re-vaccinate using a stronger vaccine-like Pfizer’s.

But UAE public health officials are strenuously warning people to not do that given that it could lead to adverse health consequences. “We note that some people may insist on taking more doses of the Covid-19 vaccine than recommended, which contradicts the opinion of doctors, and which may expose them to unwanted health complications,” the National Emergency Crisis and Disasters Management Authority said.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?


The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.